SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Archibiome tattoo for resistant, responsive, and resilient cities

The REMEDY project aims to revolutionize architecture with engineered living materials that enhance building resilience and aesthetics through custom microbial inks, promoting a probiotic approach to design.

Subsidie
€ 2.998.122
2025

Projectdetails

Introduction

The REMEDY project proposes a game-changing technology in the form of an archibiome tattoo that will allow bespoke and high-resolution decoration and functionalisation of new and existing buildings. Our ambition is to achieve a breakthrough in fundamental research in microbiology and synthetic biology, transfer the know-how to materials science in the form of engineered living materials, and develop compatible biofabrication processes that allow personalised design in the architectural context.

Customisation of Building Appearance

We propose the customisation of building appearance with living and active interkingdom microbial inks that will act similarly to probiotic skincare products, enhancing biotherapeutic architecture. The tailored and engineered microbial consortia will create a beneficial microbiome, providing:

  • Resilience and resistance against pathogenic microorganisms
  • Carbon sequestration
  • Oxygen production
  • Bioremediation

among others.

Evaluation and Analysis

We will use the latest metagenomic tools to evaluate the functionome of the created microbial consortia along every step in the development of living inks. In silico analysis will be applied to predict combinations of microorganisms based on genome-scale models of metabolism.

Machine Learning Implementation

Machine learning models will be implemented for predictive analysis of growth patterns and structural outcomes, providing insights for further optimising ink formulations and printing parameters.

Impact on the Building Industry

REMEDY will introduce metabolic thinking in the circular building industry, boost probiotic architecture, and initiate a microbial revolution that aims to change the negative perception of microorganisms in architecture. The “high-risk” idea proposed by the interdisciplinary consortium will deliver a “high-gain” solution in the form of probiotic architecture.

A New Dimension in Materials

REMEDY will provide a new dimension that has not yet existed for conventional materials – life. It will change the way we perceive, experience, understand, design, use, and transform materials.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.998.122
Totale projectbegroting€ 2.998.122

Tijdlijn

Startdatum1-2-2025
Einddatum31-1-2029
Subsidiejaar2025

Partners & Locaties

Projectpartners

  • INNORENEW COE CENTER ODLICNOSTI ZA RAZISKAVE IN INOVACIJE NA PODROCJU OBNOVLJIVIH MATERIALOV IN ZDRAVEGA BIVANJSKEGA OKOLJApenvoerder
  • UNIVERZA V LJUBLJANI
  • TECHNISCHE UNIVERSITAET GRAZ
  • TIGER Coatings
  • XYLOTRADE B.V.
  • QRES TECHNOLOGIES SRO

Land(en)

SloveniaAustriaNetherlandsSlovakia

Inhoudsopgave

EIC Pathfinder

Financiering tot €3–4 mln voor high‑risk, high‑gain onderzoek naar baanbrekende technologieën binnen Horizon Europe.

Bekijk regeling

Vergelijkbare projecten binnen EIC Pathfinder

ProjectRegelingBedragJaarActie

Bacteria Biofilm as bio-factory for tissue regeneration

BIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes.

EIC Pathfinder€ 2.903.862
2023
Details

SKIN MICROBIAL DEVICES

SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.

EIC Pathfinder€ 1.718.408
2023
Details

PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

EIC Pathfinder€ 2.805.403
2022
Details

Digital design and robotic fabrication of biofoams for adaptive mono-material architecture

The ARCHIBIOFOAM project aims to develop multifunctional, 3D-printable biofoams with programmable properties for sustainable architecture, enhancing performance while reducing CO2 emissions.

EIC Pathfinder€ 3.422.982
2024
Details

On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs

Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.

EIC Pathfinder€ 2.606.250
2022
Details
EIC Pathfinder

Bacteria Biofilm as bio-factory for tissue regeneration

BIOACTION aims to transform biofilm-associated infections into a resource for tissue regeneration using functionalized bio-hydrogels and engineered liposomes, enhancing implant technology and health outcomes.

EIC Pathfinder
€ 2.903.862
2023
Details
EIC Pathfinder

SKIN MICROBIAL DEVICES

SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.

EIC Pathfinder
€ 1.718.408
2023
Details
EIC Pathfinder

PRInted Symbiotic Materials as a dynamic platform for Living Tissues production

PRISM-LT aims to develop a flexible bioprinting platform using hybrid living materials to enhance stem cell differentiation with engineered helper cells for biomedical and food applications.

EIC Pathfinder
€ 2.805.403
2022
Details
EIC Pathfinder

Digital design and robotic fabrication of biofoams for adaptive mono-material architecture

The ARCHIBIOFOAM project aims to develop multifunctional, 3D-printable biofoams with programmable properties for sustainable architecture, enhancing performance while reducing CO2 emissions.

EIC Pathfinder
€ 3.422.982
2024
Details
EIC Pathfinder

On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs

Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.

EIC Pathfinder
€ 2.606.250
2022
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

Bioinspired living skin for architecture

The ARCHI-SKIN project aims to develop a bioactive protective coating using fungal biofilms to enhance the durability and functionality of various materials through innovative design and in-situ methods.

ERC Consolid...€ 1.999.000
2022
Details

Microbiome-based diagnostics and therapeutics

This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.

ERC Proof of...€ 150.000
2023
Details

Additive Manufacturing of Living Composite Materials

This project aims to create living composites by integrating biological systems into engineering materials, enhancing adaptability, healing, and performance through innovative fabrication techniques.

ERC Consolid...€ 1.999.491
2023
Details

InnomABs

IPA onderzoekt de haalbaarheid van het ontwikkelen van menselijke eiwitten als alternatief voor antibiotica tegen antimicrobiële resistentie.

Mkb-innovati...€ 14.888
2023
Details

Revolutionizing Skin Health with our Advanced Engineered Biotherapeutics

The SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization.

EIC Transition€ 2.499.999
2025
Details
ERC Consolid...

Bioinspired living skin for architecture

The ARCHI-SKIN project aims to develop a bioactive protective coating using fungal biofilms to enhance the durability and functionality of various materials through innovative design and in-situ methods.

ERC Consolidator Grant
€ 1.999.000
2022
Details
ERC Proof of...

Microbiome-based diagnostics and therapeutics

This project aims to develop microbiome-based diagnostic and therapeutic products by leveraging multi-omics data to identify predictive bacterial strains for disease onset and progression.

ERC Proof of Concept
€ 150.000
2023
Details
ERC Consolid...

Additive Manufacturing of Living Composite Materials

This project aims to create living composites by integrating biological systems into engineering materials, enhancing adaptability, healing, and performance through innovative fabrication techniques.

ERC Consolidator Grant
€ 1.999.491
2023
Details
Mkb-innovati...

InnomABs

IPA onderzoekt de haalbaarheid van het ontwikkelen van menselijke eiwitten als alternatief voor antibiotica tegen antimicrobiële resistentie.

Mkb-innovatiestimulering Topsectoren Haalbaarheid
€ 14.888
2023
Details
EIC Transition

Revolutionizing Skin Health with our Advanced Engineered Biotherapeutics

The SkinEngineering project aims to advance a patented biotherapeutic technology using genetically engineered skin bacteria for effective acne treatment, targeting regulatory validation and commercialization.

EIC Transition
€ 2.499.999
2025
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.